Projects per year
Fingerprint Dive into the research topics where Rafael Fonseca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 26 Similar Profiles
Multiple Myeloma
Medicine & Life Sciences
Waldenstrom Macroglobulinemia
Medicine & Life Sciences
Plasma Cells
Medicine & Life Sciences
Dexamethasone
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Monoclonal Gammopathy of Undetermined Significance
Medicine & Life Sciences
Thalidomide
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2000 2020
Mayo Clinic Multiple Myeloma SPORE
Fonseca, R., Stewart, A. K., Dueck, A., Chesi, M., Bergsagel, L., Chesi, M. & Dueck, A.
9/1/15 → 8/31/20
Project: Research project
Multiple Myeloma
Oncolytic Virotherapy
Clonal Evolution
Vesicular Stomatitis
Research
Specialized Program of Research Excellence in Myeloma
Fonseca, R., Bergsagel, L., Hideshima, T., Kufe, D. W., Anderson, K. C., Munshi, N. C., Kufe, D. W., Cozen, W., Munshi, N. C., Anderson, K. C., Weller, E., Bradner, J., Munshi, N. C. & C.Anderson, K.
9/1/03 → 8/31/18
Project: Research project
Plasma Cell Neoplasms
Multiple Myeloma
Research Personnel
Waldenstrom Macroglobulinemia
Comparative Genomic Hybridization
Chromosome Aberrations
Multiple Myeloma
Fluorescence In Situ Hybridization
Chromosomes, Human, Pair 13
Thalidomide
Research Output 1996 2019
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma
Sahin, I., Kawano, Y., Sklavenitis-Pistofidis, R., Moschetta, M., Mishima, Y., Manier, S., Sacco, A., Carrasco, R., Fonseca, R., Roccaro, A. M., Witzig, T. E. & Ghobrial, I. M., Apr 9 2019, In : Blood Advances. 3, 7, p. 995-1002 8 p.Research output: Contribution to journal › Article
Open Access
Cytokinesis
Multiple Myeloma
Growth
Neoplasms
Protein-Serine-Threonine Kinases
1
Citation
(Scopus)
Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
Kim, C., Bhatta, S., Cyprien, L., Fonseca, R. & Hernandez, R. K., Feb 1 2019, In : Journal of Bone Oncology. 14, 100215.Research output: Contribution to journal › Article
Multiple Myeloma
Incidence
History
Proteasome Inhibitors
Electronic Health Records
Monoclonal antibody utilization characteristics in patients with multiple myeloma
Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.Research output: Contribution to journal › Article
Multiple Myeloma
Monoclonal Antibodies
Premedication
Clinical Trials
Drug Utilization
MYC dysregulation in the progression of multiple myeloma
MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.Research output: Contribution to journal › Letter
Multiple Myeloma
1
Citation
(Scopus)
Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies
LeBlanc, T. W., Baile, W. F., Eggly, S., Bylund, C. L., Kurtin, S., Khurana, M., Najdi, R., Blaedel, J., Wolf, J. L. & Fonseca, R., Jan 1 2019, In : Patient Education and Counseling.Research output: Contribution to journal › Review article
Hematologic Neoplasms
Multiple Myeloma
Communication
Publications
Decision Making